MOA of Febuxostat 

Gout occurs when high levels of serum uric Acid build up in body, which can then form needle-shaped crystals in and around the joint causing Swelling and Pain in the joints.

MODE Of ACTION

  • Febuxostat is a non-purine xanthine oxidase inhibitor used to treat gout. 
  • It works by non-competitively blocking the molybdenum pterin center, which is the active site of xanthine oxidase, which catalyzes the conversion of hypoxanthine to xanthine and xanthine to uric acid. 
  • By inhibiting xanthine oxidase, febuxostat reduces the production of uric acid, which helps to lower serum uric acid levels and prevent the formation of gout crystals.


Specifically, febuxostat, a non-purine XOI, has been shown to be more effective than allopurinol at lowering serum uric acid levels in patients with gout, it have fewer side effects as it does not interfere with the metabolism of other purines.

 



Comments

Post a Comment

Popular posts from this blog

Image
Explain in detail the role of prostacyclin and thromboxane on platelet aggregation Prostacyclin and thromboxane are two opposing eicosanoids (locally-acting hormones) that play a critical role in platelet aggregation. These 2 Local hormones are produced in the Arachidonic Acid Metabolism Pathway. Role of TXA2 on platelet Aggregation: Thromboxane A2 is produced from Prostaglandin H2 by the Enzyme Thromboxane A synthase. Mature platelets express only COX-1 and releases TxA2. This TxA2 then binds with TP receptor and induces platelet Aggregation by Protein Kinase C Dependent pathways . ( increased Stickiness) PGI2 also binds with TP receptor of Vascular smooth muscle inhibiting PKC pathway causing increased cAMP level causing Vasoconstriction.   The role of TXA2 in platelet aggregation is so important that aspirin, which inhibits TXA2 production by blocking the cyclooxygenase-1 (COX-1) enzyme, is one of the most widely used antiplatelet drugs in the world. Aspirin is used t...
Read more
Image
ARACHIDONIC METABOLISM PATHWAY  Introduction Arachidonic Acid pathway describes the synthesis of different Prostanoids (PGs, TXs, Prostacyclin) and Leukotrienes, Cysteinyl Leukotrienes, and Lipoxanes. Steps of AA pathway Step – 01 (Activation of Phospholipase A 2 and release of Arachidonic Acid) Release of AA from phospholipid membrane is carried out by Phospholipase A2 Stimuli initiates the Ca+2 dependent translocation of cytosolic PLA2 to the membrane where it hydrolyses the AA and releases It into the cytosol. Step – 02 (Cyclooxygenase Pathway)  Arachidonic acid is converted to Prostaglandin G2 and Prostaglandin H2 catalyzed by Cyclooxygenase (COX-1 & COX-2) enzyme.  Prostaglandin H2 is then Converted to various Prostanoids by several enzymes- Thromboxane A2 ( Converted by Thromboxane A synthase )  Prostaglandin E2 ( Microsomal Prostaglandin E synthase and cytosolic prostaglandin E Synthase )  Prostaglandin F 2 alpha ( Prostaglandin F synthase ...
Read more
Various Therapeutic Uses of Somatostatin Analogues  Somatostatin is a hormone produced by several tissues in the body, but it is mainly found in the nervous and digestive systems . It inhibits the secretion of several other hormones in the body and also acts as a neurotransmitter. Somatostatin analogs are a synthetic form of somatostatin hormone and are used to reduce the production of various hormones in the body, particularly hormones produced by tumors. Examples of Somatostatin Analogous:    Mode of Action Therapeutic Uses Oct reotide Binds to Somatostatin Receptor (SSTR)s [Subtypes – 2,3,5] -         ¯ Pancreatic Secretion -         ¯ Gastric Acid Secretion -         ¯ Intestinal Motility -         Vasoconstriction à ¯ Blood Flow -   ...
Read more